{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:52:52Z","timestamp":1740163972024,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Colorectal carcinoma (CRC) is the third most common malignancy worldwide, and second in number of deaths in the world. The molecular pathogenesis of CRC is heterogeneous and can affect several genes. Moreover, genomic instability is recognized as an important part of CRC carcinogenesis and is tightly connected to DNA damage response. DNA damage repair (DDR) pathways are intrinsically associated with cancer development and establishment. Traditionally, CRC is considered as one coherent disease, however, new evidence shows that left and right-sided CRC present differences observed in clinical settings, as well as in pre-clinical studies. Therefore, this study aimed to investigate the impact of DDR transcriptional profiles on survival in different sublocations of the colon and rectum using Cox regression, survival analysis and differential gene expression. Right side colon (RSC) has DDR genes\u2019 expression associated only with higher risk of death, while left side colon (LSC) and Rectum have most genes\u2019 expression associated with lower risk. The pattern is the same with survival analysis. All significant DDR genes had lower expression associated with better survival in RSC, as opposed to LSC and Rectum. Our results demonstrate that RSC is distinctively different from LSC and Rectum. LSC and Rectum have similar DDR expression profiles.<\/jats:p>","DOI":"10.1038\/s41598-023-42890-9","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T10:02:23Z","timestamp":1695636143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Laterality influence on gene expression of DNA damage repair in colorectal cancer"],"prefix":"10.1038","volume":"13","author":[{"given":"Juliano","family":"Oliveira-Silveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Filippi-Chiela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5372-2934","authenticated-orcid":false,"given":"Jenifer","family":"Saffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,25]]},"reference":[{"key":"42890_CR1","unstructured":"T. I. A. for R. on Cancer (IARC), Global Cancer Observatory. Accessed Oct 31 2022 https:\/\/gco.iarc.fr\/."},{"issue":"1","key":"42890_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10689-014-9755-y","volume":"14","author":"AL Norris","year":"2015","unstructured":"Norris, A. L. et al. Familial and sporadic pancreatic cancer share the same molecular pathogenesis. Fam. Cancer 14(1), 95\u2013103. https:\/\/doi.org\/10.1007\/s10689-014-9755-y (2015).","journal-title":"Fam. Cancer"},{"issue":"2","key":"42890_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/medsci6020031","volume":"6","author":"U Testa","year":"2018","unstructured":"Testa, U., Pelosi, E. & Castelli, G. Colorectal cancer: Genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. Med. Sci. 6(2), 31. https:\/\/doi.org\/10.3390\/medsci6020031 (2018).","journal-title":"Med. Sci."},{"key":"42890_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3967","author":"J Guinney","year":"2015","unstructured":"Guinney, J. et al. The consensus molecular subtypes of colorectal cancer. Nat. Med. https:\/\/doi.org\/10.1038\/nm.3967 (2015).","journal-title":"Nat. Med."},{"issue":"17","key":"42890_CR5","doi-asserted-by":"publisher","first-page":"23312","DOI":"10.18632\/oncotarget.8196","volume":"7","author":"YK Chae","year":"2016","unstructured":"Chae, Y. K. et al. Genomic landscape of DNA repair genes in cancer. Oncotarget 7(17), 23312\u201323321. https:\/\/doi.org\/10.18632\/oncotarget.8196 (2016).","journal-title":"Oncotarget"},{"key":"42890_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/nature12625","author":"RA Burrell","year":"2013","unstructured":"Burrell, R. A., McGranahan, N., Bartek, J. & Swanton, C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature https:\/\/doi.org\/10.1038\/nature12625 (2013).","journal-title":"Nature"},{"issue":"4","key":"42890_CR7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/1878-0261.12467","volume":"13","author":"NM Reilly","year":"2019","unstructured":"Reilly, N. M., Novara, L., Di Nicolantonio, F. & Bardelli, A. Exploiting DNA repair defects in colorectal cancer. Mol. Oncol. 13(4), 681\u2013700. https:\/\/doi.org\/10.1002\/1878-0261.12467 (2019).","journal-title":"Mol. Oncol."},{"key":"42890_CR8","doi-asserted-by":"publisher","first-page":"102923","DOI":"10.1016\/j.dnarep.2020.102923","volume":"93","author":"R Ijsselsteijn","year":"2020","unstructured":"Ijsselsteijn, R., Jansen, J. G. & de Wind, N. DNA mismatch repair-dependent DNA damage responses and cancer. DNA Repair 93, 102923. https:\/\/doi.org\/10.1016\/j.dnarep.2020.102923 (2020).","journal-title":"DNA Repair"},{"key":"42890_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30342-3","author":"Y Zhang","year":"2002","unstructured":"Zhang, Y., Chen, F., Chandrashekar, D. S., Varambally, S. & Creighton, C. J. Proteogenomic characterization of, human cancers reveals pan-cancer molecular subtypes and associated pathways. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-022-30342-3 (2002).","journal-title":"Nat. Commun."},{"issue":"10","key":"42890_CR10","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s00384-016-2633-3","volume":"31","author":"MPL van der Sijp","year":"2016","unstructured":"van der Sijp, M. P. L. et al. Differences between colon and rectal cancer in complications, short-term survival and recurrences. Int. J. Colorectal Dis. 31(10), 1683\u20131691. https:\/\/doi.org\/10.1007\/s00384-016-2633-3 (2016).","journal-title":"Int. J. Colorectal Dis."},{"key":"42890_CR11","unstructured":"Wilson, D. J. & Bordoni, B. \u201cEmbryology, Bowel,\u201d in StatPearls, Treasure Island (FL). (StatPearls Publishing, 2023 accessed: Jul March 2023). http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK545247\/"},{"issue":"41","key":"42890_CR12","doi-asserted-by":"publisher","first-page":"11767","DOI":"10.3748\/wjg.v21.i41.11767","volume":"21","author":"S Vatandoust","year":"2015","unstructured":"Vatandoust, S., Price, T. J. & Karapetis, C. S. Colorectal cancer: Metastases to a single organ. World J. Gastroenterol. 21(41), 11767\u201311776. https:\/\/doi.org\/10.3748\/wjg.v21.i41.11767 (2015).","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"42890_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/DCR.0b013e3181c703a4","volume":"53","author":"F Benedix","year":"2010","unstructured":"Benedix, F. et al. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis. Colon Rectum 53(1), 57\u201364. https:\/\/doi.org\/10.1007\/DCR.0b013e3181c703a4 (2010).","journal-title":"Dis. Colon Rectum"},{"issue":"6","key":"42890_CR14","doi-asserted-by":"publisher","first-page":"e000599","DOI":"10.1136\/esmoopen-2019-000599","volume":"4","author":"M Benavides","year":"2019","unstructured":"Benavides, M. et al. Tumour location and efficacy of first-line EGFR inhibitors in KRAS\/RAS wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trials. ESMO Open 4(6), e000599. https:\/\/doi.org\/10.1136\/esmoopen-2019-000599 (2019).","journal-title":"ESMO Open"},{"issue":"6","key":"42890_CR15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3393\/ac.2019.11.11","volume":"35","author":"SK Baek","year":"2019","unstructured":"Baek, S. K. Laterality: Immunological differences between right-sided and left-sided colon cancer. Ann. Coloproctol. 35(6), 291\u2013293. https:\/\/doi.org\/10.3393\/ac.2019.11.11 (2019).","journal-title":"Ann. Coloproctol."},{"issue":"3","key":"42890_CR16","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1440-1746.2007.04923.x","volume":"23","author":"T Nawa","year":"2008","unstructured":"Nawa, T. et al. Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology. J. Gastroenterol. Hepatol. 23(3), 418\u2013423. https:\/\/doi.org\/10.1111\/j.1440-1746.2007.04923.x (2008).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"5","key":"42890_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ijc.10635","volume":"101","author":"B Iacopetta","year":"2002","unstructured":"Iacopetta, B. Are there two sides to colorectal cancer?. Int. J. Cancer 101(5), 403\u2013408. https:\/\/doi.org\/10.1002\/ijc.10635 (2002).","journal-title":"Int. J. Cancer"},{"issue":"10","key":"42890_CR18","doi-asserted-by":"publisher","first-page":"e0240408","DOI":"10.1371\/journal.pone.0240408","volume":"15","author":"C Takasu","year":"2020","unstructured":"Takasu, C. et al. Impact of sidedness of colorectal cancer on tumor immunity. PLOS ONE 15(10), e0240408. https:\/\/doi.org\/10.1371\/journal.pone.0240408 (2020).","journal-title":"PLOS ONE"},{"key":"42890_CR19","doi-asserted-by":"crossref","unstructured":"COSMIC: the Catalogue of Somatic Mutations In Cancer | Nucleic Acids Research | Oxford Academic. https:\/\/academic.oup.com\/nar\/article\/47\/D1\/D941\/5146192?login=false. (Accessed Oct. 31, 2022).","DOI":"10.1093\/nar\/gky1015"},{"key":"42890_CR20","unstructured":"Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature\u2014PMC. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6089587\/. Accessed Dec. 19, 2022)."},{"issue":"2","key":"42890_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1001\/jamaoncol.2016.4227","volume":"3","author":"F Petrelli","year":"2017","unstructured":"Petrelli, F. et al. Prognostic survival associated with left-sided vs right-sided colon cancer: A systematic review and meta-analysis. JAMA Oncol. 3(2), 211\u2013219. https:\/\/doi.org\/10.1001\/jamaoncol.2016.4227 (2017).","journal-title":"JAMA Oncol."},{"issue":"9","key":"42890_CR22","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1002\/cam4.3757","volume":"10","author":"I Azar","year":"2021","unstructured":"Azar, I. et al. The impact of primary tumor sidedness on survival in early-onset colorectal cancer by stage: A national veterans affairs retrospective analysis. Cancer Med. 10(9), 2987\u20132995. https:\/\/doi.org\/10.1002\/cam4.3757 (2021).","journal-title":"Cancer Med."},{"issue":"1","key":"42890_CR23","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1016\/j.clcc.2020.08.007","volume":"20","author":"S Malakorn","year":"2021","unstructured":"Malakorn, S. et al. Tumor sidedness, recurrence, and survival after curative resection of localized colon cancer. Clin. Colorectal Cancer 20(1), e53\u2013e60. https:\/\/doi.org\/10.1016\/j.clcc.2020.08.007 (2021).","journal-title":"Clin. Colorectal Cancer"},{"issue":"2","key":"42890_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2353\/jmoldx.2006.050052","volume":"8","author":"T Sugai","year":"2006","unstructured":"Sugai, T. et al. Analysis of molecular alterations in left- and right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis. J. Mol. Diagn. JMD 8(2), 193\u2013201. https:\/\/doi.org\/10.2353\/jmoldx.2006.050052 (2006).","journal-title":"J. Mol. Diagn. JMD"},{"issue":"3","key":"42890_CR25","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/cancers14030799","volume":"14","author":"M Belias","year":"2022","unstructured":"Belias, M. et al. Is laterality prognostic in resected kras-mutated colorectal liver metastases? A systematic review and meta-analysis. Cancers 14(3), 799. https:\/\/doi.org\/10.3390\/cancers14030799 (2022).","journal-title":"Cancers"},{"issue":"7","key":"42890_CR26","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/jso.24425","volume":"114","author":"K Sasaki","year":"2016","unstructured":"Sasaki, K. et al. The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis. J. Surg. Oncol. 114(7), 803\u2013809. https:\/\/doi.org\/10.1002\/jso.24425 (2016).","journal-title":"J. Surg. Oncol."},{"issue":"2","key":"42890_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1200\/JCO.21.02014","volume":"40","author":"M Pan","year":"2022","unstructured":"Pan, M. et al. TP53 gain-of-function and non-gain-of-function mutations are differentially associated with sidedness-dependent prognosis in metastatic colorectal cancer. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 40(2), 171\u2013179. https:\/\/doi.org\/10.1200\/JCO.21.02014 (2022).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"9","key":"42890_CR28","doi-asserted-by":"publisher","first-page":"10187","DOI":"10.1002\/cam4.5716","volume":"12","author":"W Huang","year":"2023","unstructured":"Huang, W. et al. Differences in DNA damage repair gene mutations between left- and right-sided colorectal cancer. Cancer Med. 12(9), 10187\u201310198. https:\/\/doi.org\/10.1002\/cam4.5716 (2023).","journal-title":"Cancer Med."},{"issue":"11","key":"42890_CR29","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1093\/annonc\/mdz387","volume":"30","author":"S Stintzing","year":"2019","unstructured":"Stintzing, S. et al. Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial. Ann. Oncol. 30(11), 1796\u20131803. https:\/\/doi.org\/10.1093\/annonc\/mdz387 (2019).","journal-title":"Ann. Oncol."},{"issue":"9","key":"42890_CR30","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1038\/sj.bjc.6602534","volume":"92","author":"A Buckowitz","year":"2005","unstructured":"Buckowitz, A. et al. \u201cMicrosatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases. Br. J. Cancer 92(9), 1746. https:\/\/doi.org\/10.1038\/sj.bjc.6602534 (2005).","journal-title":"Br. J. Cancer"},{"issue":"14","key":"42890_CR31","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.7150\/jca.18286","volume":"8","author":"ST Kim","year":"2017","unstructured":"Kim, S. T. et al. The impact of microsatellite instability status and sidedness of the primary tumor on the effect of cetuximab-containing chemotherapy in patients with metastatic colorectal cancer. J. Cancer 8(14), 2809\u20132815. https:\/\/doi.org\/10.7150\/jca.18286 (2017).","journal-title":"J. Cancer"},{"issue":"20","key":"42890_CR32","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1200\/JCO.2009.27.1825","volume":"28","author":"DJ Sargent","year":"2010","unstructured":"Sargent, D. J. et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 28(20), 3219\u20133226. https:\/\/doi.org\/10.1200\/JCO.2009.27.1825 (2010).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"6","key":"42890_CR33","doi-asserted-by":"publisher","first-page":"E1324","DOI":"10.3390\/ijms18061324","volume":"18","author":"A Passardi","year":"2017","unstructured":"Passardi, A., Canale, M., Valgiusti, M. & Ulivi, P. Immune checkpoints as a target for colorectal cancer treatment. Int. J. Mol. Sci. 18(6), E1324. https:\/\/doi.org\/10.3390\/ijms18061324 (2017).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42890-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42890-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42890-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T21:22:51Z","timestamp":1700515371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42890-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,25]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["42890"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-42890-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2023,9,25]]},"assertion":[{"value":"27 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing  interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15963"}}